Western Michigan University

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Coronary artery disease3 trials
• Stroke2 trials
• Heart failure1 trial
• Schizophrenia1 trial

Phase

• Phase 33 trials
• Phase 11 trial

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals2 trials
• Boehringer Ingelheim1 trial
• Janssen Research & Development, LLC1 trial
• Western Michigan University1 trial

Running trials

• Active, not recruiting

  An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

  NCT07517263· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Recruiting

  A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

  NCT07615426· Phase 1· Janssen Research & Development, LLC· Source

• Completed

  OUD Smartphone Services

  NCT06134882· Western Michigan University· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

  NCT04023552· Phase 3· Novartis Pharmaceuticals· Source